https://www.selleckchem.com/pr....oducts/noradrenaline
Device 2 was associated with a reduced risk of poor benefit (RR, 0.52; 95% CI, 0.32-0.85; p=0.009). Device 4 was associated with an increased risk of poor benefit (RR, 1.71; 95% CI, 1.14-2.55; p=0.02) and increased risk of device explantation (RR, 2.69; 95% CI, 1.2-6.02; p=0.03). Patient outcome was associated with diagnosis, postimplantation falls, and device manufacturer. Further investigation is recommended to confirm associations through prospective studies that can more accurately quantify pati
Like
Comment
Share
